Lates News

Broker Raymond James has upgraded UnitedHealth's rating from "in line with the market" to "outperform the market", with a target price of $330. It is expected that the company's earnings per share for 2027 and 2028 may exceed the market's general expectations by approximately 7.5% and 8% respectively.